Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-04

Scott A. Stuart

Role not yet determined Is this you? Add your title

6 h-index 14 pubs 351 cited

  • Humans
  • Melanoma
  • Cell Line, Tumor
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins B-raf
  • Animals
  • Models, Biological
  • Neoplastic Stem Cells
  • Mice
  • Granulocyte-Macrophage Progenitor Cells
  • Biological Evolution
  • Piperazines
  • Mitogen-Activated Protein Kinases
  • Delivery of Health Care
  • Pharmacogenetics

Biography and Research Information

OverviewAI-generated summary

Scott A. Stuart's research investigates molecular mechanisms in cancer, particularly melanoma and chronic myeloid leukemia (CML). His work has explored the effects of protein kinase inhibitors on melanoma cells, including comparative phosphoproteomic analyses of different drug treatments and adaptive resensitization to overcome resistance. Stuart has also studied the role of neoplastic stem cells in myeloid leukemias, examining their evolution from progenitor cells. His publications include research on DNA damage responses and protein degradation in transformed cells. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Amy Y. Sato, Teresita Bellido, Nisreen Akel, and Gaston Troncoso, with whom he shares multiple publications.

Metrics

  • h-index: 6
  • Publications: 14
  • Citations: 351

Selected Publications

  • THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies (2023)
    Journal of the Endocrine Society DOI OpenAlex
  • Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023)
    Bone Research DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

11 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics